{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:44:19Z","timestamp":1792842259043,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3415,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/sj.ki.5001514","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T22:51:37Z","timestamp":1152226297000},"page":"771-780","source":"Crossref","is-referenced-by-count":698,"title":["Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients"],"prefix":"10.1016","volume":"70","author":[{"given":"K.","family":"Kalantar-Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kuwae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Regidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Shinaberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Kopple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001514_bb0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.mcna.2004.12.004","article-title":"Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease","volume":"89","author":"Pendse","year":"2005","journal-title":"Med Clin N Am"},{"key":"10.1038\/sj.ki.5001514_bb0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2003.12.003","article-title":"Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy","volume":"43","author":"Martin","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/ajkd.2003.50033","article-title":"Prevalence and progression of peripheral arterial calcifications in patients with ESRD","volume":"41","author":"Kronenberg","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000084890","article-title":"Why do dialysis patients develop a heart of stone and bone of China?","volume":"23","author":"Martola","year":"2005","journal-title":"Blood Purif"},{"key":"10.1038\/sj.ki.5001514_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/sj.ki.5001514_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0272-6386(85)80091-3","article-title":"Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and \u2018epidemic\u2019 forms of the syndrome","volume":"6","author":"Norris","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0045","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study","volume":"16","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0055","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001514_bb0065","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI Clinical Practice Guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation I, Kidney Disease-Dialysis Outcome Quality Initiative","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0070","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001514_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000169030","article-title":"Hypocalcemia, morbidity, and mortality in end-stage renal disease","volume":"16","author":"Foley","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1159\/000045869","article-title":"Refeeding hypophosphatemia in a chronically hyperphosphatemic hemodialysis patient","volume":"86","author":"Koch","year":"2000","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001514_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1301\/nr.2003.sept.320-323","article-title":"The refeeding syndrome and hypophosphatemia","volume":"61","author":"Marinella","year":"2003","journal-title":"Nutr Rev"},{"key":"10.1038\/sj.ki.5001514_bb0100","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/ajkd.2001.29254","article-title":"Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation","volume":"38","author":"Avram","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/ajkd.2002.35693","article-title":"Low parathyroid hormone and pentosidine in hemodialysis patients","volume":"40","author":"Panuccio","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0110","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/gfh895","article-title":"Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study","volume":"5","author":"Kalantar-Zadeh","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001514_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-139X.2005.18408.x","article-title":"Vitamin D treatment in chronic kidney disease","volume":"18","author":"Andress","year":"2005","journal-title":"Semin Dial"},{"key":"10.1038\/sj.ki.5001514_bb0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.semnephrol.2004.06.013","article-title":"Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism","volume":"24","author":"Martin","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0125","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1053\/ajkd.2002.36899","article-title":"Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients","volume":"40","author":"Coyne","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jclinepi.2004.05.002","article-title":"Hematocrit was not validated as a surrogate end point for survival among epoietin-treated hemodialysis patients","volume":"57","author":"Cotter","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/sj.ki.5001514_bb0135","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","article-title":"Epoetin requirements predict mortality in hemodialysis patients","volume":"44","author":"Zhang","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0272-6386(97)90339-5","article-title":"High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients","volume":"29","author":"Barany","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0145","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.ajkd.2005.05.020","article-title":"Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population","volume":"46","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0155","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0160","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","article-title":"Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients","volume":"17","author":"Regidor","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0165","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/ndt\/gfh941","article-title":"Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction","volume":"20","author":"Kalantar-Zadeh","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001514_bb0170","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.V113520","article-title":"Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD","volume":"11","author":"Longenecker","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001514_bb0175","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001514_bb0180","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ije\/dyg326","article-title":"Commentary: questionable premises, overadjustment, and a smoking\/suicide association in younger adult men","volume":"32","author":"Leistikow","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1038\/sj.ki.5001514_bb0185","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/oxfordjournals.aje.a113364","article-title":"Overadjustment in case\u2013control studies","volume":"115","author":"Thompson","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1038\/sj.ki.5001514_bb0190","series-title":"Modern Epidemiology","article-title":"Sources of bias","author":"Rothman","year":"1998"},{"key":"10.1038\/sj.ki.5001514_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1467-985X.2004.00349.x","article-title":"Multiple-bias modeling for analysis of observational data (with discussion)","volume":"168","author":"Greenland","year":"2005","journal-title":"J Roy Statist Soc Ser A"},{"key":"10.1038\/sj.ki.5001514_bb0200","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000154895.18269.67","article-title":"Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions","volume":"45","author":"Kalantar-Zadeh","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5001514_bb0205","first-page":"420","article-title":"The post: pre dialysis plasma urea nitrogen ratio to estimate K.t\/V and NPCR: validation","volume":"12","author":"Daugirdas","year":"1989","journal-title":"Int J Artif Organs"},{"key":"10.1038\/sj.ki.5001514_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/jren.2003.50005","article-title":"Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt\/V greater than 1.20","volume":"13","author":"Kalantar-Zadeh","year":"2003","journal-title":"J Ren Nutr"},{"key":"10.1038\/sj.ki.5001514_bb0215","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"10.1038\/sj.ki.5001514_bb0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0272-6386(03)00915-6","article-title":"Effect of malnutrition\u2013inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients","volume":"42","author":"Kalantar-Zadeh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","article-title":"Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients","volume":"33","author":"Gunnell","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001514_bb0230","series-title":"The Statistical Analysis of Failure-Time Data","author":"Kalbfleisch","year":"2002"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815519959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815519959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T08:46:49Z","timestamp":1627548409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815519959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0085253815519959"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001514","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}